Onco BCG 40 mg Injection

Product Description

Onco BCG 40 mg Injection is an effective therapeutic option for patients diagnosed with early-stage bladder cancer, particularly for those whose tumors have not invaded the bladder muscle. This innovative vaccine functions by targeting and eliminating cancerous cells while significantly reducing the risk of cancer recurrence, thereby aiding in long-term management of the disease. Administered directly into the bladder, Onco BCG stimulates the immune system to recognize and attack malignant cells, fostering a proactive response against bladder cancer. Patients should be aware of potential side effects, including mild flu-like symptoms and bladder irritation, which may occur post-treatment. It's crucial to discuss any existing health conditions or medications with a healthcare provider before initiating therapy to ensure safety and effectiveness. With its proven efficacy, Onco BCG is a cornerstone in the fight against bladder cancer, offering hope for improved patient outcomes. Always follow your physician's instructions and attend regular follow-up appointments to monitor progress and address any concerns.